![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Zhejiang Huahai Pharmaceutical Co., Ltd. Linhai Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Captopril, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 1997-023 - Rev 10
This Chemical Type CEP, issued on October 19, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1079 associated with this CEP further emphasizes